TQH2722 injection matching placebo
Sponsors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Conditions
Atopic DermatitisSinusitis
Phase 2
A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis
NCT05970432
Start: 2023-06-19End: 2024-03-31Target: 160Updated: 2023-08-01
A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.
CompletedNCT06089278
Start: 2023-12-28End: 2025-04-30Updated: 2025-07-14